Special Report COVID-19 Impact
Pharmaceutical Engineering® COVID-19 Impact Survey: How the Industry is Responding to the Pandemic
In late April and early May, Pharmaceutical Engineering surveyed over 50 ISPE members who hold leadership positions within the Society about the pandemic’s impact. This article shares highlights from their feedback.
Engage with Health Authorities to Mitigate and Prevent Drug Shortages
This article offers an overview of the pathways for a drug manufacturer to notify and collaborate with health authorities to minimize the impact of drug shortages, whether or not there is an ongoing pandemic or large-scale disruptive event.
Pandemic Preparedness and Business Continuity
This article updates a 2006 Pharmaceutical Engineering® Online Exclusive article, “Avian Flu—Is My Company Prepared?” Although that article focused on preparation for an influenza pandemic, its key points are relevant to any type of epidemiological threat—including COVID-19.
How Vaccines Are Developed
The COVID-19 pandemic has put a spotlight on the science of vaccine development. As the world awaits a vaccine for the coronavirus, manufacturers face unprecedented pressure to respond quickly and deliver a safe and efficacious product.
